Current treatment of meningiomas

Area of Science:

• Neuro-oncology
• Molecular biology
• Endocrinology

Background:

• Intracranial meningiomas present significant clinical challenges.
• Current treatment modalities, including surgery and irradiation, are approaching technical limitations.
• Understanding the molecular basis of meningioma development is crucial for advancing therapeutic strategies.

Purpose of the Study:

• To summarize recent advances in the understanding and treatment of intracranial meningiomas.
• To explore the potential role of molecular biological factors, particularly hormones, in meningioma pathogenesis.
• To highlight the limitations of current physical therapies and the need for novel approaches.

Main Methods:

• Review of important articles and recent advances in the field.
• Analysis of molecular biological data related to hormone involvement.
• Evaluation of the efficacy and limitations of surgical and irradiation techniques.

Main Results:

• Current physical therapies for intracranial meningiomas have reached near-maximal technical effectiveness.
• Molecular biological insights, especially regarding hormonal influences, offer potential future therapeutic avenues.
• Advances in understanding tumor development are critical for improving patient outcomes.

Conclusions:

• Novel therapeutic strategies for intracranial meningiomas are needed.
• Further research into the molecular and hormonal aspects of meningiomas is warranted.
• Integrating molecular insights with existing therapies may improve treatment efficacy.